TRPV2 and Miyoshi myopathy: Moreover, we have previously reported in MM patients, that TRPV2 is heterogeneously expressed in CD138+ plasma cells and CBD administration, alone or in synergy with Bortezomib, in TRPV2 expressing cells strongly inhibits growth, arrests cell cycle progression and induces the death of MM cells [31].